SEARCH

Current Edition

Acadia

FDA panel to review once-rejected Acadia drug for psychosis

Dive Brief: After receiving a rejection last year, Acadia said Wednesday that the Food and Drug Administration agreed to review its resubmitted application to expand …

Continue Reading →
Acadia

Acadia shares rise on study success for Rett syndrome drug

No treatments are available for Rett syndrome, although a number of companies, including Acadia, aim to change that. Acadia’s drug is a synthetic version of …

Continue Reading →